Cary Street Partners Investment Advisory LLC Astrazeneca PLC Transaction History
Cary Street Partners Investment Advisory LLC
- $152 Billion
- Q4 2024
A detailed history of Cary Street Partners Investment Advisory LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 2,337 shares of AZN stock, worth $173,452. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,337
Previous 8,578
72.76%
Holding current value
$173,452
Previous $668,000
22822.16%
% of portfolio
0.1%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,356Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.48 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.04 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.78 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.75 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.78 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $230B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...